Authors:
GIESS R
GOETZ R
SCHRANK B
OCHS G
SENDTNER M
TOYKA K
Citation: R. Giess et al., POTENTIAL IMPLICATIONS OF A CILIARY NEUROTROPHIC FACTOR GENE MUTATIONIN A GERMAN POPULATION OF PATIENTS WITH MOTOR-NEURON DISEASE, Muscle & nerve, 21(2), 1998, pp. 236-238
Citation: Wh. Jost et B. Schrank, DEFECATORY DISORDERS IN DE-NOVO PARKINSONIANS - COLONIC TRANSIT AND ELECTROMYOGRAM OF THE EXTERNAL ANAL-SPHINCTER, Wiener Klinische Wochenschrift, 110(15), 1998, pp. 535-537
Authors:
OCHS G
PENN RD
GIESS R
SCHRANK B
SENDTNER M
TOYKA KV
Citation: G. Ochs et al., A TRIAL OF RECOMBINANT METHIONYL HUMAN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) GIVEN BY INTRATHECAL (IT) INFUSION TO PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS), Neurology, 50(4), 1998, pp. 21005-21005
Authors:
SENDTNER M
GRAVEL C
GOTZ R
SCHRANK B
OCHS G
TOYKA K
Citation: M. Sendtner et al., THE ROLE OF NEUROTROPHIC FACTORS IN PATHOGENESIS AND EXPERIMENTAL-THERAPY OF MOTONEURON DISEASE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 104-104
Authors:
ODERMATT A
TASCHNER PEM
SCHERER SW
BEATTY B
KHANNA VK
CORNBLATH DR
CHAUDHRY V
YEE WC
SCHRANK B
KARPATI G
BREUNING MH
KNOERS N
MACLENNAN DH
Citation: A. Odermatt et al., CHARACTERIZATION OF THE GENE ENCODING HUMAN SARCOLIPIN (SLN), A PROTEOLIPID ASSOCIATED WITH SERCA1 - ABSENCE OF STRUCTURAL MUTATIONS IN 5 PATIENTS WITH BRODY-DISEASE, Genomics, 45(3), 1997, pp. 541-553
Authors:
WINTERHOLLER M
CLAUS D
BOCKELBRINK A
BORASIO GD
PONGRATZ D
SCHRANK B
TOYKA KV
NEUNDORFER B
Citation: M. Winterholler et al., HOME VENTILATION OF ADULTS WITH NEUROMUSC ULAR DISEASES A CONSENSUS PAPER OF THE BAVARIAN CENTERS OF NEUROMUSCULAR DISEASE, Nervenarzt, 68(4), 1997, pp. 351-357
Authors:
SENDTNER M
GRAVEL C
GOTZ R
SCHRANK B
OCHS G
TOYKA K
Citation: M. Sendtner et al., NEUROTROPHIC FACTOR THERAPY IN DEGENERATIVE DISORDERS OF THE NERVOUS-SYSTEM, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 50-50
Authors:
SCHRANK B
GOTZ R
GUNNERSEN JM
URE JM
TOYKA KV
SMITH AG
SENDTNER M
Citation: B. Schrank et al., INACTIVATION OF THE SURVIVAL MOTOR-NEURON GENE, A CANDIDATE GENE FOR HUMAN SPINAL MUSCULAR-ATROPHY, LEADS TO MASSIVE CELL-DEATH IN EARLY MOUSE EMBRYOS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(18), 1997, pp. 9920-9925
Authors:
SENDTNER M
GOTZ R
DITTRICH F
OCHS G
HOLTMANN B
SCHRANK B
TOYKA KV
Citation: M. Sendtner et al., NEUROTROPHIC FACTORS FOR MOTONEURONS - PHYSIOLOGICAL FUNCTIONS AND PHARMACOLOGICAL APPLICATIONS, Journal of neurochemistry, 69, 1997, pp. 50-50
Authors:
WINTERHOLLER M
CLAUS D
BOCKELBRINK A
BORASIO GD
PONGRATZ DE
SCHRANK B
TOYKA K
NEUNDORFER B
Citation: M. Winterholler et al., REVIEW - HOME VENTILATION IN NEUROMUSCULA R DISEASES OF ADULTS - INTRODUCTION OF THE RECOMMENDATIONS OF THE BAVARIAN MUSCLE CENTERS IN THE DGM, Medizinische Klinik, 91, 1996, pp. 45-47
Authors:
ZHANG YL
FUJII J
PHILLIPS MS
CHEN HS
KARPATI G
YEE WC
SCHRANK B
CORNBLATH DR
BOYLAN KB
MACLENNAN DH
Citation: Yl. Zhang et al., CHARACTERIZATION OF CDNA AND GENOMIC DNA ENCODING SERCA1, THE CA2-ATPASE OF HUMAN FAST-TWITCH SKELETAL-MUSCLE SARCOPLASMIC-RETICULUM, AND ITS ELIMINATION AS A CANDIDATE GENE FOR BRODY DISEASE(), Genomics, 30(3), 1995, pp. 415-424